163 related articles for article (PubMed ID: 7935152)
1. [Anti-hormonal therapy in breast cancer].
Ecker-Schlipf B
Med Monatsschr Pharm; 1994 Aug; 17(8):247-50. PubMed ID: 7935152
[No Abstract] [Full Text] [Related]
2. [Hormone treatment of breast cancer].
Gröhn P
Duodecim; 1991; 107(8):603-10. PubMed ID: 1364913
[No Abstract] [Full Text] [Related]
3. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
4. A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer.
Younus J; Vandenberg TA
Bull Cancer; 2005 Apr; 92(4):E39-44. PubMed ID: 15888383
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.
Thomas S; Munster PN
Cancer Lett; 2009 Aug; 280(2):184-91. PubMed ID: 19185986
[TBL] [Abstract][Full Text] [Related]
6. Introduction to the conference, Aromatase: New Perspectives for Breast Cancer.
Santen RJ
Cancer Res; 1982 Aug; 42(8 Suppl):3268s. PubMed ID: 7083183
[No Abstract] [Full Text] [Related]
7. Optimizing endocrine therapy for breast cancer.
Winer EP
J Clin Oncol; 2005 Mar; 23(8):1609-10. PubMed ID: 15755964
[No Abstract] [Full Text] [Related]
8. [Action of SERM and SAS (tibolone) on breast tissue].
Gompel A; Jacob D; de Chambine S; Mimoun M; Decroix Y; Rostene W; Poitout P
Contracept Fertil Sex; 1999 May; 27(5):368-75. PubMed ID: 10401183
[TBL] [Abstract][Full Text] [Related]
9. [New developments in hormonal therapy for breast cancer].
Tominaga T
Gan To Kagaku Ryoho; 1996 May; 23(6):678-83. PubMed ID: 8645017
[TBL] [Abstract][Full Text] [Related]
10. [Hormonal dependence and hormonal therapy of cancers of the endometrium and breast].
Barrat J
Rev Fr Gynecol Obstet; 1985 Jul; 80(7):549-53. PubMed ID: 4035192
[TBL] [Abstract][Full Text] [Related]
11. [Medical treatments for breast cancer].
Roché H
Rev Prat; 2004 Apr; 54(8):855-64. PubMed ID: 15274459
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic results obtained with aminoglutethimide in advanced-stage breast cancer. Factors predictive of a response].
Paridaens RJ; Arrigo C; Heuson JC
Acta Clin Belg Suppl; 1986; 11():18-28. PubMed ID: 3459320
[No Abstract] [Full Text] [Related]
13. [A case of male breast cancer with special reference to the hormonal environment during chemoendocrine therapy].
Saito K; Hotta T; Kobayashi S; Miura I; Sakuma S; Shimozato T; Torii T; Iwase H; Satake A; Nishida T
Gan No Rinsho; 1985 Oct; 31(13):1727-30. PubMed ID: 3001383
[TBL] [Abstract][Full Text] [Related]
14. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
15. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Miller WR; Stuart M; Sahmoud T; Dixon JM
Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
[TBL] [Abstract][Full Text] [Related]
16. Droloxifene--a novel antiestrogen in endocrine dependent human tumors xenotransplanted into nude mice.
Stelzer P; Staab HJ; Kömpf J
Strahlenther Onkol; 1989 Jul; 165(7):559-60. PubMed ID: 2749496
[No Abstract] [Full Text] [Related]
17. The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women.
Buzdar AU; Vergote I; Sainsbury R
Breast J; 2004; 10(3):211-7. PubMed ID: 15125747
[TBL] [Abstract][Full Text] [Related]
18. Hormonal therapy of breast cancer.
Locker GY
Cancer Treat Rev; 1998 Jun; 24(3):221-40. PubMed ID: 9767736
[No Abstract] [Full Text] [Related]
19. Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body.
Gadducci A; Cosio S; Genazzani AR
Curr Opin Investig Drugs; 2004 Oct; 5(10):1031-44. PubMed ID: 15535424
[TBL] [Abstract][Full Text] [Related]
20. Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
Spicer J; Ellis P
Cancer Lett; 2007 Apr; 248(2):165-74. PubMed ID: 16919870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
